Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

FHS
June 29, 2023
10:24 am

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

Prehospital Tranexamic Acid Won’t Stave Off Disability After Severe Trauma

Initiated before hospital admission in advanced trauma systems, tranexamic acid provided an early survival benefit that ultimately failed to translate into favorable 6-month outcomes in

June 15, 2023

ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs

SAN ANTONIO — Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications among adults with obesity, weight loss results with

November 12, 2024

SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study investigates the characteristics of the EG.5.1 “Eris” variant of SARS-CoV-2, finding it more transmissible among hamsters and slightly better at evading immunity compared to

September 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.